×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
CONSIDERATIONS IN DEVELOPMENT OF COMBINATION PRODUCTS
Session Chair(s)
Manfred Maeder, PhD
Head of Device Development & Commercialization
Novartis, Switzerland
Speaker(s)
Manufacturing and Quality Aspects
Manfred Maeder, PhD
Novartis, Switzerland
Head of Device Development & Commercialization
Blake Green
Amgen, United Kingdom
Regulatory Affairs Senior Manager
Assessing Classification of Borderline Products
Shayesteh Fürst-Ladani, MBA, MS
SFL Regulatory Affairs & Scientific Communication, Switzerland
CEO
Have an account?